GHRL and neuroblastoma: The study used SH-SY5Y neuroblastoma cells, which were treated with Ghrelin, and found that Ghrelin had cell proliferative and anti-apoptotic effects that promoted cell survival, and Ghrelin also promoted the activation of the proteasome system, which, in turn, facilitated the clearance of toxic protein aggregates from the cells.